tiprankstipranks
Advertisement
Advertisement

AU:LDX Stock Latest News

Lumos Diagnostics Secures A$709,837 R&D Tax Rebate to Advance Point-of-Care Platforms
Company AnnouncementsLumos Diagnostics Secures A$709,837 R&D Tax Rebate to Advance Point-of-Care Platforms
2d ago
LDX
Lumos Diagnostics Director Sam Lanyon Increases Shareholding via On‑Market Purchase
PremiumCompany Announcements
Lumos Diagnostics Director Sam Lanyon Increases Shareholding via On‑Market Purchase
6d ago
LDX
Lumos Diagnostics Seeks ASX Quotation for 15.2 Million New Shares
PremiumCompany Announcements
Lumos Diagnostics Seeks ASX Quotation for 15.2 Million New Shares
9d ago
LDX
Lumos Diagnostics Director Catherine Robson Increases Indirect Shareholding
PremiumCompany Announcements
Lumos Diagnostics Director Catherine Robson Increases Indirect Shareholding
12d ago
LDX
Lumos Diagnostics Updates Director Doug Ward’s Expanded Equity Holding
PremiumCompany Announcements
Lumos Diagnostics Updates Director Doug Ward’s Expanded Equity Holding
26d ago
LDX
Lumos ramps up U.S. rollout of FebriDx ahead of investor briefing
PremiumCompany AnnouncementsLumos ramps up U.S. rollout of FebriDx ahead of investor briefing
27d ago
LDX
Lumos Secures BARDA Milestone as FebriDx CLIA Waiver Unlocks US$1bn Market
Premium
Company Announcements
Lumos Secures BARDA Milestone as FebriDx CLIA Waiver Unlocks US$1bn Market
2M ago
LDX
Lumos Director Catherine Robson Increases Indirect Shareholding via Purchases and Share Plan
Premium
Company Announcements
Lumos Director Catherine Robson Increases Indirect Shareholding via Purchases and Share Plan
2M ago
LDX
Lumos Director Increases Stake via Share Purchase Plan
PremiumCompany Announcements
Lumos Director Increases Stake via Share Purchase Plan
2M ago
LDX
Lumos Diagnostics Issues 44.4 Million Unlisted Options
PremiumCompany Announcements
Lumos Diagnostics Issues 44.4 Million Unlisted Options
2M ago
LDX
Lumos Diagnostics Issues 455,544 New Unlisted Options
PremiumCompany Announcements
Lumos Diagnostics Issues 455,544 New Unlisted Options
2M ago
LDX
Lumos Diagnostics Seeks ASX Quotation for 1.18 Million New Shares
PremiumCompany Announcements
Lumos Diagnostics Seeks ASX Quotation for 1.18 Million New Shares
2M ago
LDX
Lumos Diagnostics Raises Fresh Capital to Accelerate FebriDx Expansion
PremiumCompany AnnouncementsLumos Diagnostics Raises Fresh Capital to Accelerate FebriDx Expansion
2M ago
LDX
Lumos Director Increases Shareholding and Corrects Prior Holding Record
Premium
Company Announcements
Lumos Director Increases Shareholding and Corrects Prior Holding Record
2M ago
LDX
Lumos Diagnostics Launches A$20m Equity Raising via Placement and SPP
Premium
Company Announcements
Lumos Diagnostics Launches A$20m Equity Raising via Placement and SPP
2M ago
LDX
Lumos Diagnostics Wins Key U.S. Clearance as FebriDx Drives Strong Quarterly Growth
PremiumCompany Announcements
Lumos Diagnostics Wins Key U.S. Clearance as FebriDx Drives Strong Quarterly Growth
2M ago
LDX
Lumos Diagnostics Announces Lapse of Performance Rights and Options
PremiumCompany Announcements
Lumos Diagnostics Announces Lapse of Performance Rights and Options
3M ago
LDX
Lumos Diagnostics Sets Q3 FY26 Results Date and Reminds Investors of Share Purchase Plan
PremiumCompany Announcements
Lumos Diagnostics Sets Q3 FY26 Results Date and Reminds Investors of Share Purchase Plan
3M ago
LDX
Lumos Diagnostics Widens FebriDx Rollout Across WellStreet Urgent Care Network
PremiumCompany Announcements
Lumos Diagnostics Widens FebriDx Rollout Across WellStreet Urgent Care Network
3M ago
LDX
Lumos Banks US$5 Million FebriDx Milestone as CLIA Waiver Unlocks U.S. Market
PremiumCompany AnnouncementsLumos Banks US$5 Million FebriDx Milestone as CLIA Waiver Unlocks U.S. Market
3M ago
LDX
Lumos Explains Timing of Market Update on FebriDx FDA Clearance and CLIA Waiver
Premium
Company Announcements
Lumos Explains Timing of Market Update on FebriDx FDA Clearance and CLIA Waiver
3M ago
LDX
Lumos Diagnostics Launches A$2m Share Purchase Plan With Attaching Options
Premium
Company Announcements
Lumos Diagnostics Launches A$2m Share Purchase Plan With Attaching Options
3M ago
LDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >